| Followers | 42 |
| Posts | 4316 |
| Boards Moderated | 0 |
| Alias Born | 07/14/2010 |
Thursday, March 27, 2025 9:23:50 AM
I have a few discrepancies.
2022 2023 2024Total Revenue $0Operating Income -25.11M -41.38M -187.67MNet Income -24.07M -38.99M -175.85M
ProfitabilityProfit Margin 0.00%Operating Margin (ttm) 0.00%
Management EffectivenessReturn on Assets (ttm) -45.06%Return on Equity (ttm) -87.35%
Income StatementRevenue (ttm) --Revenue Per Share (ttm) --Gross Profit (ttm) --EBITDA -182.44MNet Income Avi to Common (ttm) -175.85M
Also the institutional ownership is impossible...
The fda approvals great will take time to distribute and get in the hands of people. They do have financing but are spending that per year which seems kind of wild. The raise at $46.00 they did will be gone in 9 months with current conditions. Will dry up and have no cash if doesn't litterally take off. I do like the employee package and that's what tells me this will be good long term but feel will have volatility. Especially after a 30% move.
The institutional ownership is impossible another reason think this jumped so much on news.
2022 2023 2024Total Revenue $0Operating Income -25.11M -41.38M -187.67MNet Income -24.07M -38.99M -175.85M
ProfitabilityProfit Margin 0.00%Operating Margin (ttm) 0.00%
Management EffectivenessReturn on Assets (ttm) -45.06%Return on Equity (ttm) -87.35%
Income StatementRevenue (ttm) --Revenue Per Share (ttm) --Gross Profit (ttm) --EBITDA -182.44MNet Income Avi to Common (ttm) -175.85M
Also the institutional ownership is impossible...
The fda approvals great will take time to distribute and get in the hands of people. They do have financing but are spending that per year which seems kind of wild. The raise at $46.00 they did will be gone in 9 months with current conditions. Will dry up and have no cash if doesn't litterally take off. I do like the employee package and that's what tells me this will be good long term but feel will have volatility. Especially after a 30% move.
The institutional ownership is impossible another reason think this jumped so much on news.
Recent SLNO News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:43:26 PM
- SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting DCCR Safety Timeline: SueWallSt • PR Newswire (US) • 04/30/2026 01:00:00 PM
- The Gross Law Firm Reminds Soleno Therapeutics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of May 5, 2026 - SLNO • PR Newswire (US) • 04/28/2026 01:00:00 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 04/28/2026 11:30:38 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:11:56 PM
- SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Drug Safety Risks: SueWallSt • PR Newswire (US) • 04/23/2026 01:00:00 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 04/20/2026 12:53:52 PM
- SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting DCCR Safety Timeline: SueWallSt • PR Newswire (US) • 04/16/2026 01:00:00 PM
- Folia Health Launches “BRAVE-PWS” Study to Better Understand the Real-World Experience of Prader-Willi Syndrome Caregivers • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 04/13/2026 07:49:00 AM
- SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 10:58:45 AM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/06/2026 09:17:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/06/2026 11:46:57 AM
- Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio • PR Newswire (US) • 04/06/2026 11:00:00 AM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 04/06/2026 08:15:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 12:17:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 12:15:43 AM
- SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm • PR Newswire (US) • 03/31/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/27/2026 05:16:59 PM
- SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting DCCR Safety Timeline: SueWallSt • PR Newswire (US) • 03/26/2026 01:00:00 PM
- SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/24/2026 01:00:00 PM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 03/23/2026 06:11:00 AM
- Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO • PR Newswire (US) • 03/20/2026 08:07:00 AM
- SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: SueWallSt • PR Newswire (US) • 03/19/2026 01:00:00 PM
